

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | peptidyl-proline hydroxylation (GO:0019511) | 5.18230109 |
| 2 | regulation of single stranded viral RNA replication via double stranded DNA intermediate (GO:0045091 | 5.03568351 |
| 3 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 4.92611310 |
| 4 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 4.92611310 |
| 5 | heterochromatin organization (GO:0070828) | 4.86712462 |
| 6 | DNA unwinding involved in DNA replication (GO:0006268) | 4.78152015 |
| 7 | establishment of mitochondrion localization (GO:0051654) | 4.72713661 |
| 8 | positive regulation of mitochondrial membrane permeability involved in apoptotic process (GO:1902110 | 4.71627669 |
| 9 | mitochondrial outer membrane permeabilization involved in programmed cell death (GO:1902686) | 4.71627669 |
| 10 | microtubule severing (GO:0051013) | 4.51450268 |
| 11 | protein hydroxylation (GO:0018126) | 4.43742028 |
| 12 | chaperone-mediated protein transport (GO:0072321) | 4.30756658 |
| 13 | regulation of synaptic vesicle exocytosis (GO:2000300) | 4.20223723 |
| 14 | ribosomal small subunit assembly (GO:0000028) | 4.17118117 |
| 15 | 4-hydroxyproline metabolic process (GO:0019471) | 4.12333828 |
| 16 | positive regulation of mitochondrial fission (GO:0090141) | 4.08714869 |
| 17 | DNA deamination (GO:0045006) | 4.08588796 |
| 18 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.97890121 |
| 19 | spliceosomal tri-snRNP complex assembly (GO:0000244) | 3.95136369 |
| 20 | protein import into peroxisome matrix (GO:0016558) | 3.91474949 |
| 21 | positive regulation of male gonad development (GO:2000020) | 3.87628646 |
| 22 | labyrinthine layer development (GO:0060711) | 3.85091573 |
| 23 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.81404190 |
| 24 | histone H4 deacetylation (GO:0070933) | 3.79973576 |
| 25 | translesion synthesis (GO:0019985) | 3.79558128 |
| 26 | regulation of necroptotic process (GO:0060544) | 3.71840614 |
| 27 | protein polyglutamylation (GO:0018095) | 3.70477907 |
| 28 | positive regulation of B cell differentiation (GO:0045579) | 3.70144737 |
| 29 | negative regulation of necroptotic process (GO:0060546) | 3.68015048 |
| 30 | purine-containing compound salvage (GO:0043101) | 3.67121809 |
| 31 | negative regulation of calcium ion-dependent exocytosis (GO:0045955) | 3.65245784 |
| 32 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.62315074 |
| 33 | positive regulation of mitochondrial membrane permeability (GO:0035794) | 3.59961620 |
| 34 | pyrimidine nucleobase catabolic process (GO:0006208) | 3.57414958 |
| 35 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 3.57260259 |
| 36 | establishment of mitochondrion localization, microtubule-mediated (GO:0034643) | 3.54122611 |
| 37 | mitochondrion transport along microtubule (GO:0047497) | 3.54122611 |
| 38 | necroptotic process (GO:0070266) | 3.50679622 |
| 39 | cell migration in hindbrain (GO:0021535) | 3.48828937 |
| 40 | DNA strand elongation involved in DNA replication (GO:0006271) | 3.48657730 |
| 41 | peptidyl-arginine omega-N-methylation (GO:0035247) | 3.47494543 |
| 42 | oxaloacetate metabolic process (GO:0006107) | 3.44947654 |
| 43 | protein retention in ER lumen (GO:0006621) | 3.44075564 |
| 44 | alternative mRNA splicing, via spliceosome (GO:0000380) | 3.42909808 |
| 45 | antigen processing and presentation via MHC class Ib (GO:0002475) | 3.42281325 |
| 46 | cranial nerve morphogenesis (GO:0021602) | 3.38218131 |
| 47 | definitive hemopoiesis (GO:0060216) | 3.35030411 |
| 48 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.33319041 |
| 49 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.32539299 |
| 50 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.28623434 |
| 51 | DNA strand elongation (GO:0022616) | 3.24155607 |
| 52 | peptidyl-lysine dimethylation (GO:0018027) | 3.23377611 |
| 53 | regulation of synaptic vesicle transport (GO:1902803) | 3.22798260 |
| 54 | negative regulation of mRNA splicing, via spliceosome (GO:0048025) | 3.21961598 |
| 55 | purine nucleotide salvage (GO:0032261) | 3.20805732 |
| 56 | peroxisomal transport (GO:0043574) | 3.19215625 |
| 57 | protein insertion into membrane (GO:0051205) | 3.19021696 |
| 58 | peptidyl-arginine methylation (GO:0018216) | 3.17044208 |
| 59 | peptidyl-arginine N-methylation (GO:0035246) | 3.17044208 |
| 60 | regulation of NFAT protein import into nucleus (GO:0051532) | 3.15853354 |
| 61 | negative regulation of DNA-templated transcription, elongation (GO:0032785) | 3.13419974 |
| 62 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 3.11480403 |
| 63 | protein-DNA complex disassembly (GO:0032986) | 3.10685156 |
| 64 | nucleosome disassembly (GO:0006337) | 3.10685156 |
| 65 | cerebellar granule cell differentiation (GO:0021707) | 3.10480366 |
| 66 | ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway (GO:004316 | 3.09958465 |
| 67 | synaptic vesicle exocytosis (GO:0016079) | 3.09030452 |
| 68 | creatine metabolic process (GO:0006600) | 3.06201082 |
| 69 | proximal/distal pattern formation (GO:0009954) | 3.05509773 |
| 70 | alpha-linolenic acid metabolic process (GO:0036109) | 3.04775543 |
| 71 | telomere maintenance via semi-conservative replication (GO:0032201) | 3.04194701 |
| 72 | positive regulation of granulocyte differentiation (GO:0030854) | 3.03976411 |
| 73 | positive regulation of dendritic spine morphogenesis (GO:0061003) | 3.00946075 |
| 74 | coronary vasculature morphogenesis (GO:0060977) | 2.99591947 |
| 75 | protein targeting to peroxisome (GO:0006625) | 2.98802497 |
| 76 | establishment of protein localization to peroxisome (GO:0072663) | 2.98802497 |
| 77 | protein localization to peroxisome (GO:0072662) | 2.98802497 |
| 78 | regulation of Arp2/3 complex-mediated actin nucleation (GO:0034315) | 2.98254595 |
| 79 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 2.97975908 |
| 80 | cellular hyperosmotic response (GO:0071474) | 2.97881580 |
| 81 | IMP metabolic process (GO:0046040) | 2.97410819 |
| 82 | response to nitric oxide (GO:0071731) | 2.96221269 |
| 83 | endosome to pigment granule transport (GO:0043485) | 2.94302274 |
| 84 | endosome to melanosome transport (GO:0035646) | 2.94302274 |
| 85 | glycolytic process (GO:0006096) | 2.92605106 |
| 86 | histone H3 deacetylation (GO:0070932) | 2.91888756 |
| 87 | regulation of necrotic cell death (GO:0010939) | 2.90742407 |
| 88 | viral transcription (GO:0019083) | 2.89661038 |
| 89 | intracellular estrogen receptor signaling pathway (GO:0030520) | 2.89619684 |
| 90 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 2.89452389 |
| 91 | synaptic vesicle maturation (GO:0016188) | 2.88768530 |
| 92 | negative regulation of cell size (GO:0045792) | 2.88349964 |
| 93 | histone H3-K9 methylation (GO:0051567) | 2.87205618 |
| 94 | regulation of gamma-delta T cell activation (GO:0046643) | 2.86765684 |
| 95 | pentose-phosphate shunt (GO:0006098) | 2.85516841 |
| 96 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 2.84566277 |
| 97 | cerebral cortex neuron differentiation (GO:0021895) | 2.83524452 |
| 98 | mature B cell differentiation involved in immune response (GO:0002313) | 2.81656638 |
| 99 | IMP biosynthetic process (GO:0006188) | 2.80969871 |
| 100 | postsynaptic membrane organization (GO:0001941) | 2.80694875 |
| 101 | microtubule nucleation (GO:0007020) | 2.80512280 |
| 102 | histone H3-K9 demethylation (GO:0033169) | 2.80471747 |
| 103 | central nervous system projection neuron axonogenesis (GO:0021952) | 2.78634391 |
| 104 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 2.78316680 |
| 105 | negative regulation of RNA splicing (GO:0033119) | 2.77032637 |
| 106 | mitochondrion localization (GO:0051646) | 2.76147032 |
| 107 | positive regulation of receptor biosynthetic process (GO:0010870) | 2.75890739 |
| 108 | negative regulation of transcription elongation from RNA polymerase II promoter (GO:0034244) | 2.75584512 |
| 109 | peripheral nervous system neuron development (GO:0048935) | 2.75244546 |
| 110 | DNA replication initiation (GO:0006270) | 2.74179256 |
| 111 | negative regulation of necrotic cell death (GO:0060547) | 2.73418795 |
| 112 | 3-UTR-mediated mRNA stabilization (GO:0070935) | 2.73280586 |
| 113 | mitochondrial fragmentation involved in apoptotic process (GO:0043653) | 2.73216554 |
| 114 | translational elongation (GO:0006414) | 2.72605892 |
| 115 | regulation of meiosis I (GO:0060631) | 2.72304497 |
| 116 | T cell homeostasis (GO:0043029) | 2.71924179 |
| 117 | T cell apoptotic process (GO:0070231) | 2.70518244 |
| 118 | growth hormone secretion (GO:0030252) | 2.68377090 |
| 119 | left/right pattern formation (GO:0060972) | 2.67089243 |
| 120 | lipopolysaccharide metabolic process (GO:0008653) | 2.66935506 |
| 121 | translational termination (GO:0006415) | 2.66507193 |
| 122 | glycine metabolic process (GO:0006544) | 2.65878495 |
| 123 | histone H3-K9 modification (GO:0061647) | 2.65525807 |
| 124 | lipopolysaccharide biosynthetic process (GO:0009103) | 2.65432109 |
| 125 | neurotransmitter-gated ion channel clustering (GO:0072578) | 2.64618602 |
| 126 | natural killer cell differentiation (GO:0001779) | 2.64474462 |
| 127 | NIK/NF-kappaB signaling (GO:0038061) | 2.62920038 |
| 128 | tricarboxylic acid metabolic process (GO:0072350) | 2.62874488 |
| 129 | cellular ketone body metabolic process (GO:0046950) | 2.61216766 |
| 130 | killing of cells in other organism involved in symbiotic interaction (GO:0051883) | 2.59509959 |
| 131 | disruption of cells of other organism involved in symbiotic interaction (GO:0051818) | 2.59509959 |
| 132 | negative regulation of G2/M transition of mitotic cell cycle (GO:0010972) | 2.58514868 |
| 133 | negative regulation of cell cycle G2/M phase transition (GO:1902750) | 2.58392950 |
| 134 | snRNA processing (GO:0016180) | 2.57569233 |
| 135 | mRNA splice site selection (GO:0006376) | 2.55073538 |
| 136 | cellular response to interleukin-4 (GO:0071353) | 2.54596059 |
| 137 | negative regulation of synaptic transmission, glutamatergic (GO:0051967) | 2.54595278 |
| 138 | pre-miRNA processing (GO:0031054) | 2.53912885 |
| 139 | megakaryocyte development (GO:0035855) | 2.53710164 |
| 140 | synaptonemal complex assembly (GO:0007130) | 2.53606238 |
| 141 | mast cell activation involved in immune response (GO:0002279) | 2.53492527 |
| 142 | mast cell degranulation (GO:0043303) | 2.53492527 |
| 143 | snRNA metabolic process (GO:0016073) | 2.53488050 |
| 144 | RNA localization (GO:0006403) | 2.53018454 |
| 145 | postreplication repair (GO:0006301) | 2.52476460 |
| 146 | positive regulation of synapse maturation (GO:0090129) | 2.52268349 |
| 147 | secretory granule organization (GO:0033363) | 2.52041046 |
| 148 | left/right axis specification (GO:0070986) | 2.51568127 |
| 149 | B cell receptor signaling pathway (GO:0050853) | 2.51446491 |
| 150 | nucleobase catabolic process (GO:0046113) | 2.51072163 |
| 151 | 2-oxoglutarate metabolic process (GO:0006103) | 2.50321994 |
| 152 | mast cell activation (GO:0045576) | 2.50220519 |
| 153 | negative regulation of myotube differentiation (GO:0010832) | 2.50092539 |
| 154 | regulation of B cell receptor signaling pathway (GO:0050855) | 2.50078932 |
| 155 | defense response to protozoan (GO:0042832) | 2.49438592 |
| 156 | spinal cord association neuron differentiation (GO:0021527) | 2.47549378 |
| 157 | nucleotide salvage (GO:0043173) | 2.46694306 |
| 158 | regulation of mitochondrial fission (GO:0090140) | 2.42748678 |
| 159 | G-protein coupled receptor signaling pathway coupled to cGMP nucleotide second messenger (GO:0007199 | 2.41865823 |
| 160 | layer formation in cerebral cortex (GO:0021819) | 2.41676547 |
| 161 | histone H4-K8 acetylation (GO:0043982) | 2.41282196 |
| 162 | histone H4-K5 acetylation (GO:0043981) | 2.41282196 |
| 163 | granulocyte differentiation (GO:0030851) | 2.40943017 |
| 164 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 2.40115993 |
| 165 | L-phenylalanine metabolic process (GO:0006558) | 2.40115993 |
| 166 | platelet dense granule organization (GO:0060155) | 2.40110569 |
| 167 | lymphocyte apoptotic process (GO:0070227) | 2.39812453 |
| 168 | GDP-mannose metabolic process (GO:0019673) | 2.39576475 |
| 169 | tricarboxylic acid cycle (GO:0006099) | 2.39281007 |
| 170 | organelle transport along microtubule (GO:0072384) | 2.39135288 |
| 171 | valine metabolic process (GO:0006573) | 2.39033345 |
| 172 | synaptic vesicle endocytosis (GO:0048488) | 2.38788373 |
| 173 | oxidative phosphorylation (GO:0006119) | 2.38661910 |
| 174 | succinate metabolic process (GO:0006105) | 2.38542486 |
| 175 | negative regulation of phagocytosis (GO:0050765) | 2.37300096 |
| 176 | regulation of fatty acid oxidation (GO:0046320) | 2.36759992 |
| 177 | epithelial cell differentiation involved in kidney development (GO:0035850) | 2.36554452 |
| 178 | regulation of protein heterodimerization activity (GO:0043497) | 2.36499323 |
| 179 | viral life cycle (GO:0019058) | 2.36217626 |
| 180 | regulation of synapse structural plasticity (GO:0051823) | 2.36064568 |
| 181 | mature B cell differentiation (GO:0002335) | 2.35490137 |
| 182 | angiogenesis involved in wound healing (GO:0060055) | 2.35013209 |
| 183 | nerve growth factor signaling pathway (GO:0038180) | 2.34686752 |
| 184 | telomere maintenance via recombination (GO:0000722) | 2.34606584 |
| 185 | regulation of glutamate receptor signaling pathway (GO:1900449) | 2.34274300 |
| 186 | NADPH regeneration (GO:0006740) | 2.34194640 |
| 187 | regulation of fatty acid beta-oxidation (GO:0031998) | 2.34174641 |
| 188 | positive regulation of protein homodimerization activity (GO:0090073) | 2.33202146 |
| 189 | serine family amino acid biosynthetic process (GO:0009070) | 2.33088437 |
| 190 | auditory behavior (GO:0031223) | 2.33020715 |
| 191 | positive regulation of lamellipodium assembly (GO:0010592) | 2.32731152 |
| 192 | nucleoside salvage (GO:0043174) | 2.31020878 |
| 193 | glyoxylate metabolic process (GO:0046487) | 2.30829917 |
| 194 | regulation of B cell differentiation (GO:0045577) | 2.28397976 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 5.48880052 |
| 2 | E2F7_22180533_ChIP-Seq_HELA_Human | 5.37798844 |
| 3 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 3.40385259 |
| 4 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 3.37650854 |
| 5 | SCL_19346495_ChIP-Seq_HPC-7_Human | 3.34841764 |
| 6 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 3.26024696 |
| 7 | IGF1R_20145208_ChIP-Seq_DFB_Human | 3.18056504 |
| 8 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 3.00933069 |
| 9 | MYC_22102868_ChIP-Seq_BL_Human | 2.99408630 |
| 10 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.78033850 |
| 11 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 2.69390560 |
| 12 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 2.68013603 |
| 13 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.67016471 |
| 14 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.51198721 |
| 15 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.50267516 |
| 16 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.34173495 |
| 17 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 2.28693245 |
| 18 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 2.10325378 |
| 19 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 2.09040271 |
| 20 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 2.04533968 |
| 21 | PKCTHETA_26484144_Chip-Seq_BREAST_Human | 2.02439496 |
| 22 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.97834549 |
| 23 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.94113930 |
| 24 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.92813236 |
| 25 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.90739136 |
| 26 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 1.88845469 |
| 27 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.88353408 |
| 28 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.87662737 |
| 29 | MAF_26560356_Chip-Seq_TH1_Human | 1.80472949 |
| 30 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.79039877 |
| 31 | * MYC_18358816_ChIP-ChIP_MESCs_Mouse | 1.76962413 |
| 32 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.75272556 |
| 33 | UTX_26944678_Chip-Seq_JUKART_Human | 1.72374518 |
| 34 | * VDR_24763502_ChIP-Seq_THP-1_Human | 1.71929484 |
| 35 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.70447211 |
| 36 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.66761055 |
| 37 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.64845695 |
| 38 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.64091119 |
| 39 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.63594992 |
| 40 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.63085090 |
| 41 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.62288813 |
| 42 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.61995046 |
| 43 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.60330110 |
| 44 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.60060336 |
| 45 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.59476190 |
| 46 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.58561069 |
| 47 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.57738905 |
| 48 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.56857423 |
| 49 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.56449456 |
| 50 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.56386643 |
| 51 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.55885310 |
| 52 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.54598791 |
| 53 | NANOG_21062744_ChIP-ChIP_HESCs_Human | 1.53270432 |
| 54 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.52605678 |
| 55 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 1.52230911 |
| 56 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.52201392 |
| 57 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.51603177 |
| 58 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.51512087 |
| 59 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.50744168 |
| 60 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.50089046 |
| 61 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.49616625 |
| 62 | MYB_26560356_Chip-Seq_TH2_Human | 1.49061360 |
| 63 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.48929149 |
| 64 | * NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.48904266 |
| 65 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.48538162 |
| 66 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.47797221 |
| 67 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.47493339 |
| 68 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.44488648 |
| 69 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.43702291 |
| 70 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.43639482 |
| 71 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.43459982 |
| 72 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.43172519 |
| 73 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.42542654 |
| 74 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.42178709 |
| 75 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.41452187 |
| 76 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 1.39586204 |
| 77 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.38841551 |
| 78 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 1.38609986 |
| 79 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.37760113 |
| 80 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.37519668 |
| 81 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.36782967 |
| 82 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.35691286 |
| 83 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.34770724 |
| 84 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.34028785 |
| 85 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.33321022 |
| 86 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.32764615 |
| 87 | CREM_20920259_ChIP-Seq_GC1-SPG_Mouse | 1.32167039 |
| 88 | WDR5_24793694_ChIP-Seq_LNCAP_Human | 1.32109406 |
| 89 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.31822588 |
| 90 | * ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.31334277 |
| 91 | MYB_26560356_Chip-Seq_TH1_Human | 1.30045863 |
| 92 | CREB1_20920259_ChIP-Seq_GC1-SPG_Mouse | 1.29888244 |
| 93 | * TFEB_21752829_ChIP-Seq_HELA_Human | 1.29611413 |
| 94 | * SIN3A_21632747_ChIP-Seq_MESCs_Mouse | 1.27873864 |
| 95 | * REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.27657220 |
| 96 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.27447679 |
| 97 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 1.27158113 |
| 98 | P68_20966046_ChIP-Seq_HELA_Human | 1.26233610 |
| 99 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 1.26140420 |
| 100 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.25487060 |
| 101 | * GABP_19822575_ChIP-Seq_HepG2_Human | 1.24889366 |
| 102 | * THAP11_20581084_ChIP-Seq_MESCs_Mouse | 1.23665616 |
| 103 | GATA1_26923725_Chip-Seq_HPCs_Mouse | 1.23112612 |
| 104 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.23104352 |
| 105 | CTCF_18555785_ChIP-Seq_MESCs_Mouse | 1.22599791 |
| 106 | KDM2B_26808549_Chip-Seq_K562_Human | 1.22450236 |
| 107 | TET1_21490601_ChIP-Seq_MESCs_Mouse | 1.22028043 |
| 108 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.21522814 |
| 109 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.21508690 |
| 110 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.21161520 |
| 111 | * BCL6_27268052_Chip-Seq_Bcells_Human | 1.20305576 |
| 112 | * SPI1_23127762_ChIP-Seq_K562_Human | 1.19903590 |
| 113 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.19732287 |
| 114 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 1.17908727 |
| 115 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.17645721 |
| 116 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.17475009 |
| 117 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.17225773 |
| 118 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.17103379 |
| 119 | * YY1_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.16934239 |
| 120 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.16685734 |
| 121 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.16241183 |
| 122 | RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.14098439 |
| 123 | * POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 1.14024734 |
| 124 | * HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.12868522 |
| 125 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.11404190 |
| 126 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.10756096 |
| 127 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.10742770 |
| 128 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.10178345 |
| 129 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.09607934 |
| 130 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.09583683 |
| 131 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.09283838 |
| 132 | * MYC_19030024_ChIP-ChIP_MESCs_Mouse | 1.09144490 |
| 133 | * MAF_26560356_Chip-Seq_TH2_Human | 1.06906184 |
| 134 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.06724543 |
| 135 | FOXP2_21765815_ChIP-ChIP_NEURO2A_Mouse | 1.06648046 |
| 136 | SETDB1_19884255_ChIP-Seq_MESCs_Mouse | 1.06644983 |
| 137 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 1.06499797 |
| 138 | CREB1_26743006_Chip-Seq_LNCaP_Human | 1.06448328 |
| 139 | * NCOR1_26117541_ChIP-Seq_K562_Human | 1.05613390 |
| 140 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.05296483 |
| 141 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.02989450 |
| 142 | SOX3_22085726_ChIP-Seq_NPCs_Mouse | 1.01961629 |
| 143 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 1.01806582 |
| 144 | PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 1.01662716 |
| 145 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 1.01008969 |
| 146 | CTCF_21964334_ChIP-Seq_BJAB-B_Human | 1.00334530 |
| 147 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.00327801 |
| 148 | * RBPJ_21746931_ChIP-Seq_IB4-LCL_Human | 0.99797362 |
| 149 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 0.99361947 |
| 150 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 0.99254173 |
| 151 | * FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 0.98951996 |
| 152 | CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 0.98609213 |
| 153 | * E2F4_21247883_ChIP-Seq_LYMPHOBLASTOID_Human | 0.98147843 |
| 154 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.97919877 |
| 155 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.97299698 |
| 156 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 0.96741083 |
| 157 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 0.95640459 |
| 158 | PAX6_23342162_ChIP-ChIP_BETA-FORBRAIN-LENS_Mouse | 0.94027612 |
| 159 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.93895336 |
| 160 | TBX5_21415370_ChIP-Seq_HL-1_Mouse | 0.93801968 |
| 161 | REST_19997604_ChIP-ChIP_NEURONS_Mouse | 0.93540011 |
| 162 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 0.92647700 |
| 163 | TP63_19390658_ChIP-ChIP_HaCaT_Human | 0.92580733 |
| 164 | * REST_21632747_ChIP-Seq_MESCs_Mouse | 0.92398924 |
| 165 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 0.92328805 |
| 166 | IRF1_19129219_ChIP-ChIP_H3396_Human | 0.91167143 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0004859_abnormal_synaptic_plasticity | 4.25991385 |
| 2 | MP0005423_abnormal_somatic_nervous | 4.08858856 |
| 3 | MP0005171_absent_coat_pigmentation | 3.74048143 |
| 4 | MP0005451_abnormal_body_composition | 3.24730691 |
| 5 | MP0002396_abnormal_hematopoietic_system | 3.00284167 |
| 6 | MP0000685_abnormal_immune_system | 2.84800353 |
| 7 | MP0009840_abnormal_foam_cell | 2.75893802 |
| 8 | MP0004808_abnormal_hematopoietic_stem | 2.73975380 |
| 9 | MP0002653_abnormal_ependyma_morphology | 2.72923787 |
| 10 | MP0005464_abnormal_platelet_physiology | 2.58307098 |
| 11 | MP0002139_abnormal_hepatobiliary_system | 2.51871603 |
| 12 | MP0001545_abnormal_hematopoietic_system | 2.50864665 |
| 13 | MP0005397_hematopoietic_system_phenotyp | 2.50864665 |
| 14 | MP0005409_darkened_coat_color | 2.37418834 |
| 15 | MP0001835_abnormal_antigen_presentation | 2.35240072 |
| 16 | MP0003880_abnormal_central_pattern | 2.28920780 |
| 17 | MP0004233_abnormal_muscle_weight | 2.21968844 |
| 18 | MP0003635_abnormal_synaptic_transmissio | 2.14749047 |
| 19 | MP0005360_urolithiasis | 2.06572195 |
| 20 | MP0005365_abnormal_bile_salt | 2.06387651 |
| 21 | MP0005174_abnormal_tail_pigmentation | 2.04875473 |
| 22 | MP0003136_yellow_coat_color | 2.00654043 |
| 23 | MP0001873_stomach_inflammation | 1.99221330 |
| 24 | MP0002249_abnormal_larynx_morphology | 1.98777144 |
| 25 | MP0009278_abnormal_bone_marrow | 1.95466855 |
| 26 | MP0002398_abnormal_bone_marrow | 1.92525084 |
| 27 | MP0003943_abnormal_hepatobiliary_system | 1.88915762 |
| 28 | MP0001188_hyperpigmentation | 1.85484623 |
| 29 | MP0003172_abnormal_lysosome_physiology | 1.85092376 |
| 30 | MP0003763_abnormal_thymus_physiology | 1.84215347 |
| 31 | MP0005075_abnormal_melanosome_morpholog | 1.81273374 |
| 32 | MP0003436_decreased_susceptibility_to | 1.78565981 |
| 33 | MP0005085_abnormal_gallbladder_physiolo | 1.76129829 |
| 34 | MP0003191_abnormal_cellular_cholesterol | 1.75660385 |
| 35 | MP0003300_gastrointestinal_ulcer | 1.73800861 |
| 36 | MP0005671_abnormal_response_to | 1.72215319 |
| 37 | MP0005499_abnormal_olfactory_system | 1.71040394 |
| 38 | MP0005394_taste/olfaction_phenotype | 1.71040394 |
| 39 | MP0000569_abnormal_digit_pigmentation | 1.69896505 |
| 40 | MP0000689_abnormal_spleen_morphology | 1.69691340 |
| 41 | MP0002722_abnormal_immune_system | 1.67485019 |
| 42 | MP0003656_abnormal_erythrocyte_physiolo | 1.67080671 |
| 43 | MP0001800_abnormal_humoral_immune | 1.66872604 |
| 44 | MP0000778_abnormal_nervous_system | 1.66451360 |
| 45 | MP0008569_lethality_at_weaning | 1.64756062 |
| 46 | MP0004145_abnormal_muscle_electrophysio | 1.64598605 |
| 47 | MP0003385_abnormal_body_wall | 1.63311539 |
| 48 | MP0002822_catalepsy | 1.62697480 |
| 49 | MP0006035_abnormal_mitochondrial_morpho | 1.62532016 |
| 50 | MP0002063_abnormal_learning/memory/cond | 1.60553976 |
| 51 | MP0004270_analgesia | 1.59801809 |
| 52 | MP0004130_abnormal_muscle_cell | 1.59270988 |
| 53 | MP0008995_early_reproductive_senescence | 1.58048090 |
| 54 | MP0004147_increased_porphyrin_level | 1.55131567 |
| 55 | MP0000716_abnormal_immune_system | 1.53605753 |
| 56 | MP0002429_abnormal_blood_cell | 1.53176054 |
| 57 | MP0000703_abnormal_thymus_morphology | 1.51557456 |
| 58 | MP0002452_abnormal_antigen_presenting | 1.51125266 |
| 59 | MP0001853_heart_inflammation | 1.50984710 |
| 60 | MP0004811_abnormal_neuron_physiology | 1.50933118 |
| 61 | MP0005025_abnormal_response_to | 1.50667705 |
| 62 | MP0002723_abnormal_immune_serum | 1.48551269 |
| 63 | MP0009785_altered_susceptibility_to | 1.45043710 |
| 64 | MP0000465_gastrointestinal_hemorrhage | 1.43938395 |
| 65 | MP0002420_abnormal_adaptive_immunity | 1.43400484 |
| 66 | MP0010368_abnormal_lymphatic_system | 1.42492757 |
| 67 | MP0001529_abnormal_vocalization | 1.42011748 |
| 68 | MP0001819_abnormal_immune_cell | 1.40506752 |
| 69 | MP0000955_abnormal_spinal_cord | 1.39388710 |
| 70 | MP0010094_abnormal_chromosome_stability | 1.38459326 |
| 71 | MP0005670_abnormal_white_adipose | 1.38278035 |
| 72 | MP0002166_altered_tumor_susceptibility | 1.37212648 |
| 73 | MP0000598_abnormal_liver_morphology | 1.35432658 |
| 74 | MP0010329_abnormal_lipoprotein_level | 1.34715341 |
| 75 | MP0000681_abnormal_thyroid_gland | 1.33719204 |
| 76 | MP0002064_seizures | 1.33080613 |
| 77 | MP0004858_abnormal_nervous_system | 1.31743983 |
| 78 | MP0008789_abnormal_olfactory_epithelium | 1.30609737 |
| 79 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.29140846 |
| 80 | MP0001968_abnormal_touch/_nociception | 1.29019297 |
| 81 | MP0003252_abnormal_bile_duct | 1.28603058 |
| 82 | MP0000751_myopathy | 1.28308073 |
| 83 | MP0008007_abnormal_cellular_replicative | 1.28181384 |
| 84 | MP0002572_abnormal_emotion/affect_behav | 1.27147739 |
| 85 | MP0006054_spinal_hemorrhage | 1.26299439 |
| 86 | MP0001486_abnormal_startle_reflex | 1.25907973 |
| 87 | MP0004484_altered_response_of | 1.24607942 |
| 88 | MP0006082_CNS_inflammation | 1.23889906 |
| 89 | MP0006036_abnormal_mitochondrial_physio | 1.21429599 |
| 90 | MP0002933_joint_inflammation | 1.20628521 |
| 91 | MP0008875_abnormal_xenobiotic_pharmacok | 1.20299008 |
| 92 | MP0002419_abnormal_innate_immunity | 1.20243094 |
| 93 | MP0001270_distended_abdomen | 1.20142000 |
| 94 | MP0005387_immune_system_phenotype | 1.19386562 |
| 95 | MP0001790_abnormal_immune_system | 1.19386562 |
| 96 | MP0000609_abnormal_liver_physiology | 1.18640235 |
| 97 | MP0000759_abnormal_skeletal_muscle | 1.18141262 |
| 98 | MP0002735_abnormal_chemical_nociception | 1.18095030 |
| 99 | MP0003183_abnormal_peptide_metabolism | 1.17477082 |
| 100 | MP0005000_abnormal_immune_tolerance | 1.17327237 |
| 101 | MP0002882_abnormal_neuron_morphology | 1.16020042 |
| 102 | MP0005058_abnormal_lysosome_morphology | 1.15876201 |
| 103 | MP0003866_abnormal_defecation | 1.15604171 |
| 104 | MP0000049_abnormal_middle_ear | 1.15387790 |
| 105 | MP0001986_abnormal_taste_sensitivity | 1.14262292 |
| 106 | MP0003698_abnormal_male_reproductive | 1.14187652 |
| 107 | MP0003879_abnormal_hair_cell | 1.13972484 |
| 108 | MP0002269_muscular_atrophy | 1.13280383 |
| 109 | MP0002152_abnormal_brain_morphology | 1.11410848 |
| 110 | MP0003303_peritoneal_inflammation | 1.11375793 |
| 111 | MP0002106_abnormal_muscle_physiology | 1.10750669 |
| 112 | MP0003329_amyloid_beta_deposits | 1.10047573 |
| 113 | MP0003646_muscle_fatigue | 1.08558702 |
| 114 | MP0002405_respiratory_system_inflammati | 1.08325866 |
| 115 | MP0008469_abnormal_protein_level | 1.07863457 |
| 116 | MP0008932_abnormal_embryonic_tissue | 1.07590113 |
| 117 | MP0008260_abnormal_autophagy | 1.06876587 |
| 118 | MP0005319_abnormal_enzyme/_coenzyme | 1.05237592 |
| 119 | MP0000747_muscle_weakness | 1.04776637 |
| 120 | MP0002019_abnormal_tumor_incidence | 1.04746898 |
| 121 | MP0002067_abnormal_sensory_capabilities | 1.04059176 |
| 122 | MP0003942_abnormal_urinary_system | 1.03891356 |
| 123 | MP0004510_myositis | 1.03328054 |
| 124 | MP0004133_heterotaxia | 1.00849690 |
| 125 | MP0003077_abnormal_cell_cycle | 1.00664303 |
| 126 | MP0001502_abnormal_circadian_rhythm | 1.00292187 |
| 127 | MP0009333_abnormal_splenocyte_physiolog | 1.00049898 |
| 128 | MP0000358_abnormal_cell_content/ | 0.99592559 |
| 129 | MP0000750_abnormal_muscle_regeneration | 0.99061512 |
| 130 | MP0004087_abnormal_muscle_fiber | 0.97981258 |
| 131 | MP0001845_abnormal_inflammatory_respons | 0.97542554 |
| 132 | MP0003861_abnormal_nervous_system | 0.96212667 |
| 133 | MP0002928_abnormal_bile_duct | 0.95681185 |
| 134 | MP0004947_skin_inflammation | 0.94485246 |
| 135 | MP0003806_abnormal_nucleotide_metabolis | 0.93492832 |
| 136 | MP0004185_abnormal_adipocyte_glucose | 0.92722632 |
| 137 | MP0002909_abnormal_adrenal_gland | 0.92109159 |
| 138 | MP0003123_paternal_imprinting | 0.91375931 |
| 139 | MP0003221_abnormal_cardiomyocyte_apopto | 0.90920195 |
| 140 | MP0003705_abnormal_hypodermis_morpholog | 0.90497464 |
| 141 | MP0001879_abnormal_lymphatic_vessel | 0.90214882 |
| 142 | MP0002837_dystrophic_cardiac_calcinosis | 0.89293835 |
| 143 | MP0001984_abnormal_olfaction | 0.89098161 |
| 144 | MP0009763_increased_sensitivity_to | 0.87811107 |
| 145 | MP0008961_abnormal_basal_metabolism | 0.86388159 |
| 146 | MP0005623_abnormal_meninges_morphology | 0.86334017 |
| 147 | MP0000015_abnormal_ear_pigmentation | 0.85584785 |
| 148 | MP0002066_abnormal_motor_capabilities/c | 0.85565687 |
| 149 | MP0003122_maternal_imprinting | 0.85130256 |
| 150 | MP0002557_abnormal_social/conspecific_i | 0.85116013 |
| 151 | MP0002184_abnormal_innervation | 0.85115358 |
| 152 | MP0008873_increased_physiological_sensi | 0.84750835 |
| 153 | MP0002272_abnormal_nervous_system | 0.84561060 |
| 154 | MP0005369_muscle_phenotype | 0.84560097 |
| 155 | MP0005023_abnormal_wound_healing | 0.83632479 |
| 156 | MP0002148_abnormal_hypersensitivity_rea | 0.83274936 |
| 157 | MP0001293_anophthalmia | 0.82469752 |
| 158 | MP0002752_abnormal_somatic_nervous | 0.80358483 |
| 159 | MP0005083_abnormal_biliary_tract | 0.80309597 |
| 160 | MP0010307_abnormal_tumor_latency | 0.80196676 |
| 161 | MP0005220_abnormal_exocrine_pancreas | 0.79758715 |
| 162 | MP0009745_abnormal_behavioral_response | 0.79016305 |
| 163 | MP0005666_abnormal_adipose_tissue | 0.78795797 |
| 164 | MP0006276_abnormal_autonomic_nervous | 0.78741352 |
| 165 | MP0002733_abnormal_thermal_nociception | 0.78072315 |
| 166 | MP0010155_abnormal_intestine_physiology | 0.77836694 |
| 167 | MP0001970_abnormal_pain_threshold | 0.77609260 |
| 168 | MP0002089_abnormal_postnatal_growth/wei | 0.77497548 |
| 169 | MP0003632_abnormal_nervous_system | 0.76737002 |
| 170 | MP0002095_abnormal_skin_pigmentation | 0.76621255 |
| 171 | MP0005410_abnormal_fertilization | 0.76381636 |
| 172 | MP0002734_abnormal_mechanical_nocicepti | 0.76220512 |
| 173 | MP0000490_abnormal_crypts_of | 0.75666613 |
| 174 | MP0003631_nervous_system_phenotype | 0.75599480 |
| 175 | MP0001929_abnormal_gametogenesis | 0.74567727 |
| 176 | MP0000249_abnormal_blood_vessel | 0.74267345 |
| 177 | MP0003634_abnormal_glial_cell | 0.73511662 |
| 178 | MP0000749_muscle_degeneration | 0.73065243 |
| 179 | MP0002075_abnormal_coat/hair_pigmentati | 0.72896623 |
| 180 | MP0002210_abnormal_sex_determination | 0.72341966 |
| 181 | MP0002114_abnormal_axial_skeleton | 0.71749638 |
| 182 | MP0001348_abnormal_lacrimal_gland | 0.69695612 |
| 183 | MP0003121_genomic_imprinting | 0.67898090 |
| 184 | MP0000920_abnormal_myelination | 0.67406296 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 4.08880128 |
| 2 | Thrombocytosis (HP:0001894) | 3.91845785 |
| 3 | Chronic otitis media (HP:0000389) | 3.89547406 |
| 4 | Peripheral hypomyelination (HP:0007182) | 3.64682455 |
| 5 | Nasal polyposis (HP:0100582) | 3.56404409 |
| 6 | Abnormal platelet function (HP:0011869) | 3.45058208 |
| 7 | Impaired platelet aggregation (HP:0003540) | 3.45058208 |
| 8 | Hyperglycinemia (HP:0002154) | 3.43651979 |
| 9 | Abnormal gallbladder physiology (HP:0012438) | 3.36977406 |
| 10 | Cholecystitis (HP:0001082) | 3.36977406 |
| 11 | Abnormality of the nasal mucosa (HP:0000433) | 3.36629884 |
| 12 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.29733339 |
| 13 | Prolonged bleeding time (HP:0003010) | 3.23057253 |
| 14 | Impulsivity (HP:0100710) | 3.15733028 |
| 15 | Abnormality of the lower motor neuron (HP:0002366) | 3.14671315 |
| 16 | Exercise-induced myalgia (HP:0003738) | 3.13595812 |
| 17 | Myokymia (HP:0002411) | 3.13067012 |
| 18 | Reticulocytosis (HP:0001923) | 3.10706392 |
| 19 | Hyperacusis (HP:0010780) | 3.05484321 |
| 20 | Exercise-induced muscle cramps (HP:0003710) | 3.00810097 |
| 21 | Aplastic anemia (HP:0001915) | 2.98622800 |
| 22 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.95723333 |
| 23 | Ragged-red muscle fibers (HP:0003200) | 2.92984570 |
| 24 | Abnormality of fatty-acid metabolism (HP:0004359) | 2.92271963 |
| 25 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 2.86666936 |
| 26 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 2.86666936 |
| 27 | Retinal dysplasia (HP:0007973) | 2.79120607 |
| 28 | Petechiae (HP:0000967) | 2.78725979 |
| 29 | Epistaxis (HP:0000421) | 2.76552309 |
| 30 | Focal motor seizures (HP:0011153) | 2.75664042 |
| 31 | Ketosis (HP:0001946) | 2.75363279 |
| 32 | Brushfield spots (HP:0001088) | 2.74045173 |
| 33 | Ankle clonus (HP:0011448) | 2.67813780 |
| 34 | Amyotrophic lateral sclerosis (HP:0007354) | 2.63876005 |
| 35 | Gait imbalance (HP:0002141) | 2.63515498 |
| 36 | Urinary urgency (HP:0000012) | 2.59192160 |
| 37 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 2.57478051 |
| 38 | Recurrent bronchitis (HP:0002837) | 2.50300663 |
| 39 | Congenital primary aphakia (HP:0007707) | 2.50227670 |
| 40 | Hepatocellular necrosis (HP:0001404) | 2.49025907 |
| 41 | Polycythemia (HP:0001901) | 2.45136243 |
| 42 | Medial flaring of the eyebrow (HP:0010747) | 2.44651768 |
| 43 | Tented upper lip vermilion (HP:0010804) | 2.42328790 |
| 44 | Increased cerebral lipofuscin (HP:0011813) | 2.41931935 |
| 45 | High anterior hairline (HP:0009890) | 2.39526710 |
| 46 | Late onset (HP:0003584) | 2.37859148 |
| 47 | Hyperammonemia (HP:0001987) | 2.37208515 |
| 48 | Occipital encephalocele (HP:0002085) | 2.35556808 |
| 49 | Tetraplegia (HP:0002445) | 2.35281738 |
| 50 | Abnormality of the corticospinal tract (HP:0002492) | 2.34350557 |
| 51 | Hypoplasia of the thymus (HP:0000778) | 2.34060233 |
| 52 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.33413020 |
| 53 | Chest pain (HP:0100749) | 2.31603788 |
| 54 | Hepatic necrosis (HP:0002605) | 2.31186161 |
| 55 | IgM deficiency (HP:0002850) | 2.30648395 |
| 56 | Abnormality of the aortic arch (HP:0012303) | 2.29405021 |
| 57 | Papilledema (HP:0001085) | 2.27661864 |
| 58 | Broad distal phalanx of finger (HP:0009836) | 2.24576869 |
| 59 | Atelectasis (HP:0100750) | 2.22957050 |
| 60 | Cortical dysplasia (HP:0002539) | 2.22474147 |
| 61 | Thyroid-stimulating hormone excess (HP:0002925) | 2.22291957 |
| 62 | Abnormality of the thoracic spine (HP:0100711) | 2.20833614 |
| 63 | Dysmetric saccades (HP:0000641) | 2.20822787 |
| 64 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 2.19287194 |
| 65 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 2.19287194 |
| 66 | Rhabdomyolysis (HP:0003201) | 2.18936761 |
| 67 | Spastic paraplegia (HP:0001258) | 2.17734340 |
| 68 | Ketoacidosis (HP:0001993) | 2.16581279 |
| 69 | Ependymoma (HP:0002888) | 2.15523450 |
| 70 | Tubulointerstitial nephritis (HP:0001970) | 2.15032558 |
| 71 | Nephrogenic diabetes insipidus (HP:0009806) | 2.14441398 |
| 72 | Abnormality of the left ventricular outflow tract (HP:0011103) | 2.13819370 |
| 73 | Subaortic stenosis (HP:0001682) | 2.13819370 |
| 74 | Genetic anticipation (HP:0003743) | 2.13764122 |
| 75 | Abnormal number of erythroid precursors (HP:0012131) | 2.13154321 |
| 76 | Neonatal respiratory distress (HP:0002643) | 2.12577377 |
| 77 | Delusions (HP:0000746) | 2.12228021 |
| 78 | Neoplasm of head and neck (HP:0012288) | 2.12215964 |
| 79 | Esophageal neoplasm (HP:0100751) | 2.12215964 |
| 80 | Elfin facies (HP:0004428) | 2.12103839 |
| 81 | Spastic gait (HP:0002064) | 2.11187518 |
| 82 | Postural instability (HP:0002172) | 2.10416600 |
| 83 | EMG: neuropathic changes (HP:0003445) | 2.10054676 |
| 84 | Gastrointestinal inflammation (HP:0004386) | 2.09255385 |
| 85 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.08535018 |
| 86 | Dicarboxylic aciduria (HP:0003215) | 2.08535018 |
| 87 | Urinary bladder sphincter dysfunction (HP:0002839) | 2.07822001 |
| 88 | Lower limb muscle weakness (HP:0007340) | 2.07471124 |
| 89 | Epiphyseal stippling (HP:0010655) | 2.07125588 |
| 90 | Myositis (HP:0100614) | 2.05425152 |
| 91 | Decreased number of large peripheral myelinated nerve fibers (HP:0003387) | 2.04158345 |
| 92 | Broad foot (HP:0001769) | 2.03093688 |
| 93 | Adenoma sebaceum (HP:0009720) | 2.02233528 |
| 94 | Angiofibromas (HP:0010615) | 2.02233528 |
| 95 | Abnormality of the intervertebral disk (HP:0005108) | 2.01676956 |
| 96 | Delayed CNS myelination (HP:0002188) | 2.01644086 |
| 97 | Supranuclear gaze palsy (HP:0000605) | 2.01461009 |
| 98 | Increased muscle lipid content (HP:0009058) | 2.00623113 |
| 99 | Abnormality of the fingertips (HP:0001211) | 2.00512466 |
| 100 | Insomnia (HP:0100785) | 2.00062708 |
| 101 | Poor coordination (HP:0002370) | 1.99956028 |
| 102 | Loss of speech (HP:0002371) | 1.99879960 |
| 103 | Bowel incontinence (HP:0002607) | 1.99850862 |
| 104 | Recurrent viral infections (HP:0004429) | 1.99284440 |
| 105 | Menorrhagia (HP:0000132) | 1.99284164 |
| 106 | Medulloblastoma (HP:0002885) | 1.97861197 |
| 107 | Abnormality of cells of the erythroid lineage (HP:0012130) | 1.97506297 |
| 108 | Polygenic inheritance (HP:0010982) | 1.97409573 |
| 109 | Myopathic facies (HP:0002058) | 1.96895669 |
| 110 | Pancytopenia (HP:0001876) | 1.96886951 |
| 111 | Deep venous thrombosis (HP:0002625) | 1.95171717 |
| 112 | Disinhibition (HP:0000734) | 1.94866650 |
| 113 | Myoglobinuria (HP:0002913) | 1.94093513 |
| 114 | Abnormal platelet volume (HP:0011876) | 1.92732818 |
| 115 | Cellulitis (HP:0100658) | 1.91674523 |
| 116 | Visual hallucinations (HP:0002367) | 1.91491641 |
| 117 | Neoplasm of the heart (HP:0100544) | 1.91310639 |
| 118 | Depression (HP:0000716) | 1.90917544 |
| 119 | Amaurosis fugax (HP:0100576) | 1.90743774 |
| 120 | Paraplegia (HP:0010550) | 1.90180113 |
| 121 | Abnormality of alanine metabolism (HP:0010916) | 1.89155777 |
| 122 | Hyperalaninemia (HP:0003348) | 1.89155777 |
| 123 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 1.89155777 |
| 124 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 1.88818180 |
| 125 | Hypoplasia of the brainstem (HP:0002365) | 1.88750757 |
| 126 | Aplasia/Hypoplasia of the brainstem (HP:0007362) | 1.88750757 |
| 127 | Type II lissencephaly (HP:0007260) | 1.88362580 |
| 128 | Abnormality of serine family amino acid metabolism (HP:0010894) | 1.88202073 |
| 129 | Abnormality of glycine metabolism (HP:0010895) | 1.88202073 |
| 130 | Hypoplasia of the iris (HP:0007676) | 1.87723327 |
| 131 | Atrophy/Degeneration involving motor neurons (HP:0007373) | 1.87485648 |
| 132 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 1.86332293 |
| 133 | Thoracic kyphosis (HP:0002942) | 1.86103820 |
| 134 | Purpura (HP:0000979) | 1.85658048 |
| 135 | Scapular winging (HP:0003691) | 1.85263670 |
| 136 | Deep palmar crease (HP:0006191) | 1.83992074 |
| 137 | Large eyes (HP:0001090) | 1.83966916 |
| 138 | Self-mutilation (HP:0000742) | 1.83200123 |
| 139 | Abnormal large intestine physiology (HP:0012700) | 1.82941376 |
| 140 | True hermaphroditism (HP:0010459) | 1.82640214 |
| 141 | Bronchitis (HP:0012387) | 1.82504611 |
| 142 | Chronic hepatic failure (HP:0100626) | 1.82302829 |
| 143 | Hand muscle atrophy (HP:0009130) | 1.82222856 |
| 144 | Asymmetric septal hypertrophy (HP:0001670) | 1.81774647 |
| 145 | Steppage gait (HP:0003376) | 1.81406254 |
| 146 | Prominent nasal bridge (HP:0000426) | 1.81172509 |
| 147 | Sensorimotor neuropathy (HP:0007141) | 1.80101161 |
| 148 | Spontaneous hematomas (HP:0007420) | 1.79147758 |
| 149 | Gonadotropin excess (HP:0000837) | 1.78746926 |
| 150 | Chronic sinusitis (HP:0011109) | 1.78367821 |
| 151 | Neuronal loss in central nervous system (HP:0002529) | 1.77426639 |
| 152 | Cerebellar dysplasia (HP:0007033) | 1.77388306 |
| 153 | Aggressive behavior (HP:0000718) | 1.76998011 |
| 154 | Scanning speech (HP:0002168) | 1.76872689 |
| 155 | Decreased testicular size (HP:0008734) | 1.76619986 |
| 156 | Lymphangioma (HP:0100764) | 1.76500055 |
| 157 | Hypercortisolism (HP:0001578) | 1.76474419 |
| 158 | Focal seizures (HP:0007359) | 1.75906094 |
| 159 | Abnormality of reticulocytes (HP:0004312) | 1.74623665 |
| 160 | Abnormality of pyrimidine metabolism (HP:0004353) | 1.73998387 |
| 161 | Agnosia (HP:0010524) | 1.73793841 |
| 162 | Increased intramyocellular lipid droplets (HP:0012240) | 1.73428543 |
| 163 | Inflammation of the large intestine (HP:0002037) | 1.73424807 |
| 164 | Gonadal dysgenesis (HP:0000133) | 1.73244280 |
| 165 | Atonic seizures (HP:0010819) | 1.73015251 |
| 166 | Abnormality of the phalanges of the hallux (HP:0010057) | 1.72397699 |
| 167 | Broad palm (HP:0001169) | 1.72364305 |
| 168 | Heterotopia (HP:0002282) | 1.72331888 |
| 169 | Striae distensae (HP:0001065) | 1.72161644 |
| 170 | Heterochromia iridis (HP:0001100) | 1.71776519 |
| 171 | Deformed sella turcica (HP:0002681) | 1.71498795 |
| 172 | Poor suck (HP:0002033) | 1.69686357 |
| 173 | Rimmed vacuoles (HP:0003805) | 1.69455227 |
| 174 | Cardiomegaly (HP:0001640) | 1.69293393 |
| 175 | Cone-shaped epiphyses of the phalanges of the hand (HP:0010230) | 1.69242431 |
| 176 | Abnormality of T cell physiology (HP:0011840) | 1.68720345 |
| 177 | Death in childhood (HP:0003819) | 1.68465501 |
| 178 | Conjunctival telangiectasia (HP:0000524) | 1.68031694 |
| 179 | Drooling (HP:0002307) | 1.67956786 |
| 180 | Open mouth (HP:0000194) | 1.67945116 |
| 181 | Reticulocytopenia (HP:0001896) | 1.67915840 |
| 182 | Short 5th finger (HP:0009237) | 1.67043100 |
| 183 | Renovascular hypertension (HP:0100817) | 1.66936504 |
| 184 | Spastic diplegia (HP:0001264) | 1.66338771 |
| 185 | Panhypogammaglobulinemia (HP:0003139) | 1.66176148 |
| 186 | Shoulder girdle muscle weakness (HP:0003547) | 1.66172957 |
| 187 | Neonatal onset (HP:0003623) | 1.66039558 |
| 188 | Increased mean platelet volume (HP:0011877) | 1.65858560 |
| 189 | Partial agenesis of the corpus callosum (HP:0001338) | 1.65834429 |
| 190 | Trigonocephaly (HP:0000243) | 1.65446830 |
| 191 | Specific learning disability (HP:0001328) | 1.65359038 |
| 192 | Truncal obesity (HP:0001956) | 1.65212159 |
| 193 | Colitis (HP:0002583) | 1.64981531 |
| 194 | Gingival bleeding (HP:0000225) | 1.63722527 |
| 195 | Thrombophlebitis (HP:0004418) | 1.63535076 |
| 196 | Postaxial foot polydactyly (HP:0001830) | 1.63414776 |
| 197 | Morphological abnormality of the pyramidal tract (HP:0002062) | 1.63344374 |
| 198 | Hyperbilirubinemia (HP:0002904) | 1.62260755 |
| 199 | Neurodegeneration (HP:0002180) | 1.62225462 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | PKN2 | 3.45393918 |
| 2 | MAP4K1 | 3.09947356 |
| 3 | TRIB3 | 2.97567040 |
| 4 | CDK12 | 2.88914317 |
| 5 | PRKD3 | 2.69921466 |
| 6 | FLT3 | 2.67009381 |
| 7 | CCNB1 | 2.57856373 |
| 8 | EPHA4 | 2.56037358 |
| 9 | MAP3K11 | 2.55734263 |
| 10 | TGFBR1 | 2.51869213 |
| 11 | TAOK3 | 2.49581094 |
| 12 | MAP3K10 | 2.46587641 |
| 13 | KIT | 2.46186990 |
| 14 | SCYL2 | 2.43460474 |
| 15 | EEF2K | 2.29595982 |
| 16 | BCKDK | 2.28876370 |
| 17 | MAP2K7 | 2.17432829 |
| 18 | MARK1 | 2.08865531 |
| 19 | ACVR1B | 2.08032549 |
| 20 | TYRO3 | 1.99989065 |
| 21 | WEE1 | 1.92429475 |
| 22 | NME2 | 1.90612147 |
| 23 | ERN1 | 1.87078255 |
| 24 | CDK19 | 1.79251263 |
| 25 | NEK9 | 1.77314833 |
| 26 | MAP3K4 | 1.75460477 |
| 27 | EIF2AK1 | 1.72640624 |
| 28 | ZAP70 | 1.71434571 |
| 29 | CSNK1A1L | 1.71350794 |
| 30 | MAP2K3 | 1.64095989 |
| 31 | BTK | 1.62903470 |
| 32 | DYRK3 | 1.55084601 |
| 33 | PAK4 | 1.54615126 |
| 34 | CSNK1G3 | 1.54007880 |
| 35 | MARK2 | 1.53775713 |
| 36 | CSNK1G2 | 1.50374720 |
| 37 | RPS6KA4 | 1.48085594 |
| 38 | CAMK1G | 1.47838235 |
| 39 | PBK | 1.46843328 |
| 40 | MAP3K7 | 1.45220319 |
| 41 | TYK2 | 1.43773690 |
| 42 | MAP2K4 | 1.40391886 |
| 43 | RIPK4 | 1.39833531 |
| 44 | KSR2 | 1.37146295 |
| 45 | CASK | 1.36943714 |
| 46 | TBK1 | 1.36674543 |
| 47 | PRPF4B | 1.32779556 |
| 48 | BRSK1 | 1.31844136 |
| 49 | SYK | 1.31500918 |
| 50 | PIM2 | 1.28205520 |
| 51 | RAF1 | 1.24316496 |
| 52 | MATK | 1.23725888 |
| 53 | BRD4 | 1.23380507 |
| 54 | BCR | 1.20895458 |
| 55 | NTRK2 | 1.20697831 |
| 56 | LRRK2 | 1.19748557 |
| 57 | CSF1R | 1.19287644 |
| 58 | PASK | 1.16916040 |
| 59 | TESK2 | 1.16194776 |
| 60 | EPHB1 | 1.15277225 |
| 61 | DAPK1 | 1.14627643 |
| 62 | CDC7 | 1.14381120 |
| 63 | TXK | 1.14242971 |
| 64 | PAK6 | 1.12501683 |
| 65 | KDR | 1.11228900 |
| 66 | CAMK4 | 1.09146974 |
| 67 | CSNK1G1 | 1.08987112 |
| 68 | GRK6 | 1.08180078 |
| 69 | TGFBR2 | 1.05427213 |
| 70 | MOS | 1.05347327 |
| 71 | NEK1 | 1.05310594 |
| 72 | FGFR4 | 1.02774466 |
| 73 | PTK6 | 1.00188308 |
| 74 | CDK4 | 0.98455213 |
| 75 | RIPK1 | 0.96998433 |
| 76 | EIF2AK3 | 0.95872076 |
| 77 | TIE1 | 0.95168100 |
| 78 | JAK3 | 0.90678527 |
| 79 | CDK11A | 0.88565205 |
| 80 | MAP3K6 | 0.88301115 |
| 81 | CAMK1D | 0.88168353 |
| 82 | UHMK1 | 0.87448739 |
| 83 | PINK1 | 0.84602368 |
| 84 | OBSCN | 0.83263848 |
| 85 | ICK | 0.82857614 |
| 86 | RPS6KA2 | 0.82161116 |
| 87 | PIK3CG | 0.81940371 |
| 88 | CDK5 | 0.81833032 |
| 89 | FES | 0.79194341 |
| 90 | LATS1 | 0.78941549 |
| 91 | TNK2 | 0.78132039 |
| 92 | ARAF | 0.77408212 |
| 93 | CDK14 | 0.76652445 |
| 94 | MAPK12 | 0.76612192 |
| 95 | DYRK2 | 0.74325774 |
| 96 | LMTK2 | 0.73338123 |
| 97 | ILK | 0.73243673 |
| 98 | BRAF | 0.72520075 |
| 99 | SIK1 | 0.72185044 |
| 100 | CDK15 | 0.71688882 |
| 101 | CDK18 | 0.70911593 |
| 102 | NEK2 | 0.69931861 |
| 103 | PLK2 | 0.68262308 |
| 104 | RPS6KL1 | 0.66134970 |
| 105 | RPS6KC1 | 0.66134970 |
| 106 | CAMKK1 | 0.64552464 |
| 107 | TEC | 0.64075371 |
| 108 | RPS6KA6 | 0.63040748 |
| 109 | RET | 0.61643475 |
| 110 | MAPK10 | 0.61217918 |
| 111 | MAPK13 | 0.61116977 |
| 112 | CLK1 | 0.60722431 |
| 113 | PTK2B | 0.60624737 |
| 114 | STK10 | 0.57884954 |
| 115 | MAP3K1 | 0.56153322 |
| 116 | BUB1 | 0.55966419 |
| 117 | PRKD2 | 0.55598387 |
| 118 | * MAPK7 | 0.55502638 |
| 119 | EPHB2 | 0.55120568 |
| 120 | MAP3K12 | 0.54806027 |
| 121 | ATR | 0.54480179 |
| 122 | MINK1 | 0.54367652 |
| 123 | CDK6 | 0.53949496 |
| 124 | KSR1 | 0.53913284 |
| 125 | BMPR1B | 0.53563948 |
| 126 | DYRK1A | 0.52762374 |
| 127 | HCK | 0.50485210 |
| 128 | TRIM28 | 0.49537424 |
| 129 | AKT2 | 0.49267276 |
| 130 | LCK | 0.49161450 |
| 131 | CAMKK2 | 0.48675839 |
| 132 | SIK2 | 0.48220955 |
| 133 | MUSK | 0.47687114 |
| 134 | CAMK1 | 0.47377904 |
| 135 | MAP3K13 | 0.47044102 |
| 136 | SIK3 | 0.46881894 |
| 137 | MAPKAPK3 | 0.46664968 |
| 138 | TESK1 | 0.45560151 |
| 139 | DYRK1B | 0.44362032 |
| 140 | CDK7 | 0.44291159 |
| 141 | CDK9 | 0.43566558 |
| 142 | IKBKE | 0.43049586 |
| 143 | NTRK3 | 0.43037240 |
| 144 | MAPK9 | 0.42928026 |
| 145 | JAK2 | 0.42181358 |
| 146 | CDK2 | 0.41756619 |
| 147 | SRPK1 | 0.41585907 |
| 148 | STK16 | 0.41402512 |
| 149 | MAPK4 | 0.41243966 |
| 150 | LYN | 0.40570487 |
| 151 | MAPKAPK2 | 0.40258933 |
| 152 | ITK | 0.40248823 |
| 153 | MAPK11 | 0.39145945 |
| 154 | HIPK2 | 0.38672588 |
| 155 | PDPK1 | 0.36754880 |
| 156 | PLK4 | 0.36695483 |
| 157 | MTOR | 0.36627807 |
| 158 | MAP2K6 | 0.36555710 |
| 159 | GSK3B | 0.36526325 |
| 160 | CDK8 | 0.36383217 |
| 161 | MAP3K9 | 0.36085003 |
| 162 | SGK3 | 0.35095765 |
| 163 | RPS6KA3 | 0.33135944 |
| 164 | CHEK1 | 0.32160440 |
| 165 | MAPK8 | 0.32020301 |
| 166 | BMPR2 | 0.31898802 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | DNA replication_Homo sapiens_hsa03030 | 3.94678304 |
| 2 | Mismatch repair_Homo sapiens_hsa03430 | 2.93434715 |
| 3 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 2.91649519 |
| 4 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.57732840 |
| 5 | Base excision repair_Homo sapiens_hsa03410 | 2.43251603 |
| 6 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 2.40827624 |
| 7 | Carbon metabolism_Homo sapiens_hsa01200 | 2.02439138 |
| 8 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 2.00986119 |
| 9 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.96626540 |
| 10 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.96352642 |
| 11 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.92840829 |
| 12 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.90693088 |
| 13 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.88384533 |
| 14 | Nicotine addiction_Homo sapiens_hsa05033 | 1.77285597 |
| 15 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.76194530 |
| 16 | Long-term potentiation_Homo sapiens_hsa04720 | 1.71391044 |
| 17 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.66635384 |
| 18 | Shigellosis_Homo sapiens_hsa05131 | 1.65046239 |
| 19 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.62822731 |
| 20 | GABAergic synapse_Homo sapiens_hsa04727 | 1.61533241 |
| 21 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.58868849 |
| 22 | Notch signaling pathway_Homo sapiens_hsa04330 | 1.55844607 |
| 23 | Peroxisome_Homo sapiens_hsa04146 | 1.52446672 |
| 24 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.51948779 |
| 25 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.51938097 |
| 26 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.50882993 |
| 27 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.49202711 |
| 28 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.48955991 |
| 29 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 1.48754875 |
| 30 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.47324504 |
| 31 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 1.47213526 |
| 32 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 1.44944494 |
| 33 | Ribosome_Homo sapiens_hsa03010 | 1.43266258 |
| 34 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.40923720 |
| 35 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.37396767 |
| 36 | Renal cell carcinoma_Homo sapiens_hsa05211 | 1.35773006 |
| 37 | Basal cell carcinoma_Homo sapiens_hsa05217 | 1.34064623 |
| 38 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 1.33725560 |
| 39 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.29360215 |
| 40 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.28711118 |
| 41 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 1.26167567 |
| 42 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.25324818 |
| 43 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 1.25175613 |
| 44 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.25112909 |
| 45 | Dopaminergic synapse_Homo sapiens_hsa04728 | 1.23046943 |
| 46 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 1.22305377 |
| 47 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.22213173 |
| 48 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 1.20840005 |
| 49 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.19768758 |
| 50 | Morphine addiction_Homo sapiens_hsa05032 | 1.19569537 |
| 51 | Homologous recombination_Homo sapiens_hsa03440 | 1.19037138 |
| 52 | ErbB signaling pathway_Homo sapiens_hsa04012 | 1.15775560 |
| 53 | Circadian entrainment_Homo sapiens_hsa04713 | 1.15625680 |
| 54 | Melanogenesis_Homo sapiens_hsa04916 | 1.13858538 |
| 55 | Platelet activation_Homo sapiens_hsa04611 | 1.13258410 |
| 56 | Sulfur relay system_Homo sapiens_hsa04122 | 1.13176879 |
| 57 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.11729245 |
| 58 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 1.10742496 |
| 59 | AMPK signaling pathway_Homo sapiens_hsa04152 | 1.09980076 |
| 60 | Endometrial cancer_Homo sapiens_hsa05213 | 1.09440823 |
| 61 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.08413627 |
| 62 | Axon guidance_Homo sapiens_hsa04360 | 1.08287456 |
| 63 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.07694629 |
| 64 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 1.06029258 |
| 65 | Glutamatergic synapse_Homo sapiens_hsa04724 | 1.05912865 |
| 66 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 1.03323622 |
| 67 | mTOR signaling pathway_Homo sapiens_hsa04150 | 1.02927967 |
| 68 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.02136969 |
| 69 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.02134545 |
| 70 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.01711354 |
| 71 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.01300632 |
| 72 | Cocaine addiction_Homo sapiens_hsa05030 | 1.00888471 |
| 73 | Spliceosome_Homo sapiens_hsa03040 | 0.99454376 |
| 74 | Long-term depression_Homo sapiens_hsa04730 | 0.98004517 |
| 75 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.97353177 |
| 76 | Cell cycle_Homo sapiens_hsa04110 | 0.96709731 |
| 77 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.96671234 |
| 78 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.95537955 |
| 79 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.95148065 |
| 80 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.94919530 |
| 81 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.93326527 |
| 82 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.92519922 |
| 83 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.91614202 |
| 84 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.90727799 |
| 85 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.89921358 |
| 86 | Measles_Homo sapiens_hsa05162 | 0.89337044 |
| 87 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.87438944 |
| 88 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.87361725 |
| 89 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.86468667 |
| 90 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.84923209 |
| 91 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.84596981 |
| 92 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.84438366 |
| 93 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.83880751 |
| 94 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.83840202 |
| 95 | Leishmaniasis_Homo sapiens_hsa05140 | 0.83690347 |
| 96 | Glioma_Homo sapiens_hsa05214 | 0.83246053 |
| 97 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.82958344 |
| 98 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.81053523 |
| 99 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.79893311 |
| 100 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.79144131 |
| 101 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.79030848 |
| 102 | ABC transporters_Homo sapiens_hsa02010 | 0.77313208 |
| 103 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.75925032 |
| 104 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.75677943 |
| 105 | * MAPK signaling pathway_Homo sapiens_hsa04010 | 0.75396460 |
| 106 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.75071710 |
| 107 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.75032746 |
| 108 | * Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.74168685 |
| 109 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.73435797 |
| 110 | Proteasome_Homo sapiens_hsa03050 | 0.72845423 |
| 111 | Lysine degradation_Homo sapiens_hsa00310 | 0.69971862 |
| 112 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.69867487 |
| 113 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.69660130 |
| 114 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.68628497 |
| 115 | * Gap junction_Homo sapiens_hsa04540 | 0.68386900 |
| 116 | Other glycan degradation_Homo sapiens_hsa00511 | 0.67816562 |
| 117 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.67624999 |
| 118 | * Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.67366549 |
| 119 | Hepatitis B_Homo sapiens_hsa05161 | 0.66821770 |
| 120 | Endocytosis_Homo sapiens_hsa04144 | 0.65916099 |
| 121 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.65597530 |
| 122 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.64632673 |
| 123 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.64554536 |
| 124 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.64047779 |
| 125 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.62559597 |
| 126 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.62424573 |
| 127 | Prion diseases_Homo sapiens_hsa05020 | 0.60336467 |
| 128 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.59772802 |
| 129 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.59729942 |
| 130 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.59671234 |
| 131 | Colorectal cancer_Homo sapiens_hsa05210 | 0.59396570 |
| 132 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.58779413 |
| 133 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.58567415 |
| 134 | Alcoholism_Homo sapiens_hsa05034 | 0.57728382 |
| 135 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.56432490 |
| 136 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.56378049 |
| 137 | Taste transduction_Homo sapiens_hsa04742 | 0.55533178 |
| 138 | RNA transport_Homo sapiens_hsa03013 | 0.55353837 |
| 139 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.54462287 |
| 140 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.54446076 |
| 141 | Legionellosis_Homo sapiens_hsa05134 | 0.53572204 |
| 142 | Apoptosis_Homo sapiens_hsa04210 | 0.53132549 |
| 143 | Thyroid cancer_Homo sapiens_hsa05216 | 0.52590145 |
| 144 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.52176323 |
| 145 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.52174101 |
| 146 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.51764644 |
| 147 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.50452453 |
| 148 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.46801700 |
| 149 | HTLV-I infection_Homo sapiens_hsa05166 | 0.45448173 |
| 150 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.45236037 |
| 151 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.43855205 |
| 152 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.43786511 |
| 153 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.43585703 |
| 154 | Insulin resistance_Homo sapiens_hsa04931 | 0.40491218 |
| 155 | Galactose metabolism_Homo sapiens_hsa00052 | 0.39818509 |
| 156 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.38797767 |
| 157 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.38772007 |
| 158 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.38522137 |
| 159 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.37863134 |
| 160 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.37600686 |
| 161 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.36991209 |
| 162 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.35903805 |

